Skip to main content
ATXS logo
ATXS
(NASDAQ)
Astria Therapeutics, Inc.
$12.58-- (--)
Loading... - Market loading

Astria Therapeutics (ATXS) Stock Price & Financial Analysis

Astria Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.58 - $12.58
52-Week High$13.29
52-Week Low$3.56
Open$12.58
Market Cap729.71M
Shares Outstanding58.01M
Price to Sales (P/S)1033.59
Price to Book (P/B)3.13
EV/EBITDA-4.67
Revenue (TTM)706.00K
Net Income (TTM)-124.03M
Free Cash Flow (TTM)-120.32M
EPS (TTM)$-2.14
Profit Margin-17567.99%
Operating Margin-19335.69%
Return on Equity (ROE)-53.17%
Debt to Equity0.02
50-Day MA$12.74
200-Day MA$8.32
52-Week Change66.62%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Astria Therapeutics

What is the current stock price for ATXS?

As of the latest trading session, ATXS stock trades at $12.58. The 52-week range is $3.56–$13.29, with a day range of $12.58–$12.58.

What is the P/E ratio for ATXS?

The P/E ratio (Price-to-Earnings) for ATXS is shown in the Key Statistics section. This valuation metric helps compare Astria Therapeutics, Inc. to industry peers.

Does ATXS pay dividends?

Astria Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATXS?

Analyst ratings and recommendations for ATXS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ATXS?

Astria Therapeutics's market capitalization is $729.7M, classifying it as a small-cap company. Astria Therapeutics operates in the Healthcare sector within the Biotechnology industry.